Ledger.Open graph →
SEC Form D · filed October 2, 2014

Adaptimmune Ltd

Offering
$103.8M
Sold
$103.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ABINGDON, OXFORDSHIRE, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Ali Behbahani · Timonium, MDDirectorDavid Mott · Leiden, P7DirectorJames Noble · Abingdon, Oxfordshire, United KingdomExec · DirectorSonia Friedman · London, United KingdomDirectorDavid Mott · Palo Alto, CADirectorPeter Thompson · Seattle, WADirectorElliott Sigal · Princeton, NJDirectorDr. Jonathan Knowles · Abingdon, Oxfordshire, United KingdomDirectorIan Laing · Abingdon, Oxfordshire, United KingdomDirectorJon Schneidman · NEW YORK, NYDirectorDavid Mott · Timonium, MDDirectorPeter Thompson · New York, NYDirectorElliott Sigal · Princeton, NJDirectorDr. Jonathan Knowles · Abingdon, Oxfordshire, United KingdomDirectorJames Noble · Abingdon, Oxfordshire, United KingdomExec · DirectorIan Laing · Abingdon, Oxfordshire, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗